BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,020,924 | -22.0% | 80,045 | -5.9% | 0.03% | -19.0% |
| Q2 2023 | $3,874,976 | +14.1% | 85,053 | +1.6% | 0.04% | +10.5% |
| Q1 2023 | $3,395,730 | -39.7% | 83,722 | -24.2% | 0.04% | -40.6% |
| Q4 2022 | $5,630,220 | -16.9% | 110,462 | -12.2% | 0.06% | -22.9% |
| Q3 2022 | $6,775,000 | -18.5% | 125,823 | -2.8% | 0.08% | -14.4% |
| Q2 2022 | $8,309,000 | -18.7% | 129,412 | -1.6% | 0.10% | -10.2% |
| Q1 2022 | $10,218,000 | -13.6% | 131,503 | -4.5% | 0.11% | -7.7% |
| Q4 2021 | $11,823,000 | +3.0% | 137,731 | -3.6% | 0.12% | -3.3% |
| Q3 2021 | $11,475,000 | -10.3% | 142,899 | -10.3% | 0.12% | -4.0% |
| Q2 2021 | $12,798,000 | -19.0% | 159,225 | -15.0% | 0.13% | -28.4% |
| Q1 2021 | $15,798,000 | +5.6% | 187,378 | +0.4% | 0.18% | +2.3% |
| Q4 2020 | $14,965,000 | +4.7% | 186,557 | +4.8% | 0.17% | -9.9% |
| Q3 2020 | $14,299,000 | -13.6% | 178,016 | -7.4% | 0.19% | -20.4% |
| Q2 2020 | $16,557,000 | -20.2% | 192,302 | -25.0% | 0.24% | -17.2% |
| Q1 2020 | $20,761,000 | +29.5% | 256,312 | +33.7% | 0.29% | +32.4% |
| Q4 2019 | $16,034,000 | -5.5% | 191,717 | -1.3% | 0.22% | -14.1% |
| Q3 2019 | $16,975,000 | +6.0% | 194,242 | -0.8% | 0.26% | +6.2% |
| Q2 2019 | $16,011,000 | -6.6% | 195,840 | -7.3% | 0.24% | -13.7% |
| Q1 2019 | $17,142,000 | +22.8% | 211,262 | -0.3% | 0.28% | +9.9% |
| Q4 2018 | $13,958,000 | -10.0% | 211,868 | +5.3% | 0.25% | +3.3% |
| Q3 2018 | $15,512,000 | -0.2% | 201,215 | -4.4% | 0.24% | -5.8% |
| Q2 2018 | $15,537,000 | +14.1% | 210,469 | +0.7% | 0.26% | +12.6% |
| Q1 2018 | $13,622,000 | +0.6% | 208,951 | -0.4% | 0.23% | -2.1% |
| Q4 2017 | $13,540,000 | +4.2% | 209,799 | +1.3% | 0.24% | -4.5% |
| Q3 2017 | $12,997,000 | +3.9% | 207,010 | +0.1% | 0.25% | -1.6% |
| Q2 2017 | $12,511,000 | +15.1% | 206,723 | -1.5% | 0.25% | +10.1% |
| Q1 2017 | $10,870,000 | +25.0% | 209,778 | +6.8% | 0.23% | +15.7% |
| Q4 2016 | $8,696,000 | +8.5% | 196,427 | +17.0% | 0.20% | +4.2% |
| Q3 2016 | $8,018,000 | +46.9% | 167,904 | +39.9% | 0.19% | +50.0% |
| Q2 2016 | $5,457,000 | +29.9% | 120,011 | +16.6% | 0.13% | +23.5% |
| Q1 2016 | $4,200,000 | +25.6% | 102,949 | +18.4% | 0.10% | +22.9% |
| Q4 2015 | $3,343,000 | -19.1% | 86,951 | -31.0% | 0.08% | -23.9% |
| Q3 2015 | $4,130,000 | -53.0% | 126,034 | -0.1% | 0.11% | -51.6% |
| Q2 2015 | $8,795,000 | -11.7% | 126,144 | -13.3% | 0.22% | -12.5% |
| Q1 2015 | $9,962,000 | -5.6% | 145,482 | +0.8% | 0.26% | -7.6% |
| Q4 2014 | $10,558,000 | +21.9% | 144,286 | +19.6% | 0.28% | +15.4% |
| Q3 2014 | $8,658,000 | +53.1% | 120,624 | +54.1% | 0.24% | +50.6% |
| Q2 2014 | $5,655,000 | -4.8% | 78,268 | -3.1% | 0.16% | -8.6% |
| Q1 2014 | $5,942,000 | +31.3% | 80,760 | +23.9% | 0.18% | +33.6% |
| Q4 2013 | $4,524,000 | +87.9% | 65,174 | +78.8% | 0.13% | +74.7% |
| Q3 2013 | $2,408,000 | -4.0% | 36,452 | +0.7% | 0.08% | -2.6% |
| Q2 2013 | $2,508,000 | – | 36,183 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |